Aknamed
Signals mentioning Aknamed
- PharmEasy rights issue signals valuation plunge from 2021 peak
- PharmEasy's ₹2,400 crore rights issue to repay debt resurfaces from July 2023
- API Holdings repays ₹1,050 crore debt, releases pledge on Thyrocare stake
- PharmEasy parent API Holdings withdraws Rs 6,250 cr DRHP, eyes rights issue